nodes	percent_of_prediction	percent_of_DWPC	metapath
Methylphenidate—CYP2D6—Lomustine—brain cancer	0.234	0.569	CbGbCtD
Methylphenidate—CYP2D6—Hydroxyurea—brain cancer	0.177	0.431	CbGbCtD
Methylphenidate—SLC6A3—telencephalic ventricle—brain cancer	0.0136	0.123	CbGeAlD
Methylphenidate—SLC6A3—ganglion—brain cancer	0.00846	0.0763	CbGeAlD
Methylphenidate—SLC6A4—ganglion—brain cancer	0.00776	0.0699	CbGeAlD
Methylphenidate—SLC6A2—ganglion—brain cancer	0.00683	0.0615	CbGeAlD
Methylphenidate—SLC6A3—hindbrain—brain cancer	0.00642	0.0579	CbGeAlD
Methylphenidate—SLC6A4—hindbrain—brain cancer	0.00588	0.053	CbGeAlD
Methylphenidate—SLC6A3—brainstem—brain cancer	0.00368	0.0332	CbGeAlD
Methylphenidate—SLC6A4—brainstem—brain cancer	0.00337	0.0304	CbGeAlD
Methylphenidate—SLC6A3—telencephalon—brain cancer	0.00326	0.0294	CbGeAlD
Methylphenidate—SLC6A4—telencephalon—brain cancer	0.00299	0.027	CbGeAlD
Methylphenidate—SLC6A2—brainstem—brain cancer	0.00297	0.0268	CbGeAlD
Methylphenidate—CYP2D6—hindbrain—brain cancer	0.00284	0.0256	CbGeAlD
Methylphenidate—SLC6A2—telencephalon—brain cancer	0.00263	0.0237	CbGeAlD
Methylphenidate—SLC6A3—midbrain—brain cancer	0.00234	0.0211	CbGeAlD
Methylphenidate—SLC6A3—spinal cord—brain cancer	0.00229	0.0206	CbGeAlD
Methylphenidate—SLC6A2—gonad—brain cancer	0.0022	0.0198	CbGeAlD
Methylphenidate—SLC6A4—midbrain—brain cancer	0.00215	0.0194	CbGeAlD
Methylphenidate—SLC6A4—spinal cord—brain cancer	0.0021	0.0189	CbGeAlD
Methylphenidate—SLC6A2—medulla oblongata—brain cancer	0.00207	0.0187	CbGeAlD
Methylphenidate—SLC6A3—head—brain cancer	0.00203	0.0183	CbGeAlD
Methylphenidate—SLC6A4—endocrine gland—brain cancer	0.00189	0.017	CbGeAlD
Methylphenidate—SLC6A4—head—brain cancer	0.00186	0.0168	CbGeAlD
Methylphenidate—SLC6A3—central nervous system—brain cancer	0.00186	0.0167	CbGeAlD
Methylphenidate—SLC6A3—cerebellum—brain cancer	0.00181	0.0163	CbGeAlD
Methylphenidate—SLC6A4—central nervous system—brain cancer	0.0017	0.0153	CbGeAlD
Methylphenidate—SLC6A2—endocrine gland—brain cancer	0.00166	0.015	CbGeAlD
Methylphenidate—SLC6A2—head—brain cancer	0.00164	0.0148	CbGeAlD
Methylphenidate—CYP2D6—brainstem—brain cancer	0.00163	0.0146	CbGeAlD
Methylphenidate—SLC6A2—central nervous system—brain cancer	0.0015	0.0135	CbGeAlD
Methylphenidate—SLC6A3—brain—brain cancer	0.00147	0.0133	CbGeAlD
Methylphenidate—CYP2D6—telencephalon—brain cancer	0.00144	0.013	CbGeAlD
Methylphenidate—SLC6A4—brain—brain cancer	0.00135	0.0122	CbGeAlD
Methylphenidate—SLC6A2—brain—brain cancer	0.00119	0.0107	CbGeAlD
Methylphenidate—CYP2D6—endocrine gland—brain cancer	0.00091	0.0082	CbGeAlD
Methylphenidate—CYP2D6—head—brain cancer	0.000898	0.00809	CbGeAlD
Methylphenidate—Nausea—Lomustine—brain cancer	0.00083	0.00174	CcSEcCtD
Methylphenidate—CYP2D6—central nervous system—brain cancer	0.00082	0.00739	CbGeAlD
Methylphenidate—Musculoskeletal discomfort—Procarbazine—brain cancer	0.000808	0.00169	CcSEcCtD
Methylphenidate—Insomnia—Procarbazine—brain cancer	0.000802	0.00168	CcSEcCtD
Methylphenidate—CYP2D6—cerebellum—brain cancer	0.000801	0.00722	CbGeAlD
Methylphenidate—Paraesthesia—Procarbazine—brain cancer	0.000796	0.00167	CcSEcCtD
Methylphenidate—Hepatobiliary disease—Temozolomide—brain cancer	0.000795	0.00166	CcSEcCtD
Methylphenidate—Sinusitis—Temozolomide—brain cancer	0.000789	0.00165	CcSEcCtD
Methylphenidate—Somnolence—Procarbazine—brain cancer	0.000788	0.00165	CcSEcCtD
Methylphenidate—Cramp muscle—Etoposide—brain cancer	0.000786	0.00164	CcSEcCtD
Methylphenidate—Haemoglobin—Carmustine—brain cancer	0.000785	0.00164	CcSEcCtD
Methylphenidate—Haemorrhage—Carmustine—brain cancer	0.000781	0.00163	CcSEcCtD
Methylphenidate—Ill-defined disorder—Hydroxyurea—brain cancer	0.00078	0.00163	CcSEcCtD
Methylphenidate—Anaemia—Hydroxyurea—brain cancer	0.000777	0.00163	CcSEcCtD
Methylphenidate—Hallucination—Carmustine—brain cancer	0.000777	0.00163	CcSEcCtD
Methylphenidate—Decreased appetite—Procarbazine—brain cancer	0.000771	0.00161	CcSEcCtD
Methylphenidate—Alanine aminotransferase increased—Etoposide—brain cancer	0.00077	0.00161	CcSEcCtD
Methylphenidate—Connective tissue disorder—Carmustine—brain cancer	0.000767	0.00161	CcSEcCtD
Methylphenidate—Fatigue—Procarbazine—brain cancer	0.000765	0.0016	CcSEcCtD
Methylphenidate—Haemoglobin—Temozolomide—brain cancer	0.000759	0.00159	CcSEcCtD
Methylphenidate—Malaise—Hydroxyurea—brain cancer	0.000758	0.00159	CcSEcCtD
Methylphenidate—Pain—Procarbazine—brain cancer	0.000758	0.00159	CcSEcCtD
Methylphenidate—Constipation—Procarbazine—brain cancer	0.000758	0.00159	CcSEcCtD
Methylphenidate—Haemorrhage—Temozolomide—brain cancer	0.000755	0.00158	CcSEcCtD
Methylphenidate—Leukopenia—Hydroxyurea—brain cancer	0.000753	0.00157	CcSEcCtD
Methylphenidate—Visual impairment—Carmustine—brain cancer	0.000753	0.00157	CcSEcCtD
Methylphenidate—Hallucination—Temozolomide—brain cancer	0.000751	0.00157	CcSEcCtD
Methylphenidate—Pharyngitis—Temozolomide—brain cancer	0.000749	0.00157	CcSEcCtD
Methylphenidate—Urinary tract disorder—Temozolomide—brain cancer	0.000745	0.00156	CcSEcCtD
Methylphenidate—Connective tissue disorder—Temozolomide—brain cancer	0.000742	0.00155	CcSEcCtD
Methylphenidate—Urethral disorder—Temozolomide—brain cancer	0.00074	0.00155	CcSEcCtD
Methylphenidate—Feeling abnormal—Procarbazine—brain cancer	0.000731	0.00153	CcSEcCtD
Methylphenidate—Eye disorder—Carmustine—brain cancer	0.00073	0.00153	CcSEcCtD
Methylphenidate—Convulsion—Hydroxyurea—brain cancer	0.000729	0.00152	CcSEcCtD
Methylphenidate—Visual impairment—Temozolomide—brain cancer	0.000727	0.00152	CcSEcCtD
Methylphenidate—Gastrointestinal pain—Procarbazine—brain cancer	0.000725	0.00152	CcSEcCtD
Methylphenidate—Flushing—Carmustine—brain cancer	0.000725	0.00152	CcSEcCtD
Methylphenidate—Pancytopenia—Etoposide—brain cancer	0.000717	0.0015	CcSEcCtD
Methylphenidate—Erythema multiforme—Temozolomide—brain cancer	0.000714	0.00149	CcSEcCtD
Methylphenidate—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—brain cancer	0.000711	0.00149	CcSEcCtD
Methylphenidate—Discomfort—Hydroxyurea—brain cancer	0.000707	0.00148	CcSEcCtD
Methylphenidate—Eye disorder—Temozolomide—brain cancer	0.000705	0.00148	CcSEcCtD
Methylphenidate—Urticaria—Procarbazine—brain cancer	0.000705	0.00147	CcSEcCtD
Methylphenidate—Abdominal pain—Procarbazine—brain cancer	0.000701	0.00147	CcSEcCtD
Methylphenidate—Body temperature increased—Procarbazine—brain cancer	0.000701	0.00147	CcSEcCtD
Methylphenidate—Flushing—Temozolomide—brain cancer	0.0007	0.00146	CcSEcCtD
Methylphenidate—Cardiac disorder—Temozolomide—brain cancer	0.0007	0.00146	CcSEcCtD
Methylphenidate—Arrhythmia—Carmustine—brain cancer	0.000698	0.00146	CcSEcCtD
Methylphenidate—Alopecia—Carmustine—brain cancer	0.00069	0.00144	CcSEcCtD
Methylphenidate—Oedema—Hydroxyurea—brain cancer	0.000686	0.00144	CcSEcCtD
Methylphenidate—Angiopathy—Temozolomide—brain cancer	0.000685	0.00143	CcSEcCtD
Methylphenidate—Mental disorder—Carmustine—brain cancer	0.000684	0.00143	CcSEcCtD
Methylphenidate—Infection—Hydroxyurea—brain cancer	0.000682	0.00143	CcSEcCtD
Methylphenidate—Immune system disorder—Temozolomide—brain cancer	0.000682	0.00143	CcSEcCtD
Methylphenidate—Mediastinal disorder—Temozolomide—brain cancer	0.00068	0.00142	CcSEcCtD
Methylphenidate—Erythema—Carmustine—brain cancer	0.00068	0.00142	CcSEcCtD
Methylphenidate—Malnutrition—Carmustine—brain cancer	0.00068	0.00142	CcSEcCtD
Methylphenidate—Chills—Temozolomide—brain cancer	0.000677	0.00142	CcSEcCtD
Methylphenidate—Pneumonia—Etoposide—brain cancer	0.000677	0.00142	CcSEcCtD
Methylphenidate—Nervous system disorder—Hydroxyurea—brain cancer	0.000673	0.00141	CcSEcCtD
Methylphenidate—Infestation—Etoposide—brain cancer	0.000673	0.00141	CcSEcCtD
Methylphenidate—Infestation NOS—Etoposide—brain cancer	0.000673	0.00141	CcSEcCtD
Methylphenidate—Thrombocytopenia—Hydroxyurea—brain cancer	0.000672	0.00141	CcSEcCtD
Methylphenidate—Stevens-Johnson syndrome—Etoposide—brain cancer	0.000667	0.00139	CcSEcCtD
Methylphenidate—Alopecia—Temozolomide—brain cancer	0.000667	0.00139	CcSEcCtD
Methylphenidate—Skin disorder—Hydroxyurea—brain cancer	0.000667	0.00139	CcSEcCtD
Methylphenidate—Acute coronary syndrome—Etoposide—brain cancer	0.000663	0.00139	CcSEcCtD
Methylphenidate—Mental disorder—Temozolomide—brain cancer	0.000661	0.00138	CcSEcCtD
Methylphenidate—Myocardial infarction—Etoposide—brain cancer	0.000659	0.00138	CcSEcCtD
Methylphenidate—Back pain—Carmustine—brain cancer	0.000658	0.00138	CcSEcCtD
Methylphenidate—Erythema—Temozolomide—brain cancer	0.000657	0.00137	CcSEcCtD
Methylphenidate—Malnutrition—Temozolomide—brain cancer	0.000657	0.00137	CcSEcCtD
Methylphenidate—Anorexia—Hydroxyurea—brain cancer	0.000654	0.00137	CcSEcCtD
Methylphenidate—Hypersensitivity—Procarbazine—brain cancer	0.000653	0.00137	CcSEcCtD
Methylphenidate—CYP2D6—brain—brain cancer	0.000651	0.00587	CbGeAlD
Methylphenidate—Vision blurred—Carmustine—brain cancer	0.000641	0.00134	CcSEcCtD
Methylphenidate—Tremor—Carmustine—brain cancer	0.000637	0.00133	CcSEcCtD
Methylphenidate—Asthenia—Procarbazine—brain cancer	0.000636	0.00133	CcSEcCtD
Methylphenidate—Hepatobiliary disease—Etoposide—brain cancer	0.000636	0.00133	CcSEcCtD
Methylphenidate—Back pain—Temozolomide—brain cancer	0.000635	0.00133	CcSEcCtD
Methylphenidate—Anaemia—Carmustine—brain cancer	0.000628	0.00131	CcSEcCtD
Methylphenidate—Pruritus—Procarbazine—brain cancer	0.000627	0.00131	CcSEcCtD
Methylphenidate—Agitation—Carmustine—brain cancer	0.000625	0.00131	CcSEcCtD
Methylphenidate—Vision blurred—Temozolomide—brain cancer	0.000619	0.00129	CcSEcCtD
Methylphenidate—Tremor—Temozolomide—brain cancer	0.000616	0.00129	CcSEcCtD
Methylphenidate—Dyspnoea—Hydroxyurea—brain cancer	0.000612	0.00128	CcSEcCtD
Methylphenidate—Somnolence—Hydroxyurea—brain cancer	0.00061	0.00128	CcSEcCtD
Methylphenidate—Ill-defined disorder—Temozolomide—brain cancer	0.00061	0.00127	CcSEcCtD
Methylphenidate—Leukopenia—Carmustine—brain cancer	0.000609	0.00127	CcSEcCtD
Methylphenidate—Anaemia—Temozolomide—brain cancer	0.000607	0.00127	CcSEcCtD
Methylphenidate—Diarrhoea—Procarbazine—brain cancer	0.000607	0.00127	CcSEcCtD
Methylphenidate—Dyspepsia—Hydroxyurea—brain cancer	0.000604	0.00126	CcSEcCtD
Methylphenidate—Agitation—Temozolomide—brain cancer	0.000604	0.00126	CcSEcCtD
Methylphenidate—Angioedema—Temozolomide—brain cancer	0.0006	0.00126	CcSEcCtD
Methylphenidate—Decreased appetite—Hydroxyurea—brain cancer	0.000597	0.00125	CcSEcCtD
Methylphenidate—Urinary tract disorder—Etoposide—brain cancer	0.000596	0.00125	CcSEcCtD
Methylphenidate—Gastrointestinal disorder—Hydroxyurea—brain cancer	0.000593	0.00124	CcSEcCtD
Methylphenidate—Malaise—Temozolomide—brain cancer	0.000592	0.00124	CcSEcCtD
Methylphenidate—Urethral disorder—Etoposide—brain cancer	0.000592	0.00124	CcSEcCtD
Methylphenidate—Fatigue—Hydroxyurea—brain cancer	0.000592	0.00124	CcSEcCtD
Methylphenidate—Vertigo—Temozolomide—brain cancer	0.00059	0.00123	CcSEcCtD
Methylphenidate—Convulsion—Carmustine—brain cancer	0.000589	0.00123	CcSEcCtD
Methylphenidate—Leukopenia—Temozolomide—brain cancer	0.000588	0.00123	CcSEcCtD
Methylphenidate—Hypertension—Carmustine—brain cancer	0.000587	0.00123	CcSEcCtD
Methylphenidate—Constipation—Hydroxyurea—brain cancer	0.000587	0.00123	CcSEcCtD
Methylphenidate—Pain—Hydroxyurea—brain cancer	0.000587	0.00123	CcSEcCtD
Methylphenidate—Dizziness—Procarbazine—brain cancer	0.000586	0.00123	CcSEcCtD
Methylphenidate—Palpitations—Temozolomide—brain cancer	0.000581	0.00121	CcSEcCtD
Methylphenidate—Chest pain—Carmustine—brain cancer	0.000579	0.00121	CcSEcCtD
Methylphenidate—Myalgia—Carmustine—brain cancer	0.000579	0.00121	CcSEcCtD
Methylphenidate—Anxiety—Carmustine—brain cancer	0.000577	0.00121	CcSEcCtD
Methylphenidate—Cough—Temozolomide—brain cancer	0.000573	0.0012	CcSEcCtD
Methylphenidate—Erythema multiforme—Etoposide—brain cancer	0.000571	0.00119	CcSEcCtD
Methylphenidate—Convulsion—Temozolomide—brain cancer	0.000569	0.00119	CcSEcCtD
Methylphenidate—Hypertension—Temozolomide—brain cancer	0.000567	0.00119	CcSEcCtD
Methylphenidate—Feeling abnormal—Hydroxyurea—brain cancer	0.000566	0.00118	CcSEcCtD
Methylphenidate—Eye disorder—Etoposide—brain cancer	0.000564	0.00118	CcSEcCtD
Methylphenidate—Vomiting—Procarbazine—brain cancer	0.000564	0.00118	CcSEcCtD
Methylphenidate—Cardiac disorder—Etoposide—brain cancer	0.00056	0.00117	CcSEcCtD
Methylphenidate—Flushing—Etoposide—brain cancer	0.00056	0.00117	CcSEcCtD
Methylphenidate—Confusional state—Carmustine—brain cancer	0.000559	0.00117	CcSEcCtD
Methylphenidate—Myalgia—Temozolomide—brain cancer	0.000559	0.00117	CcSEcCtD
Methylphenidate—Arthralgia—Temozolomide—brain cancer	0.000559	0.00117	CcSEcCtD
Methylphenidate—Rash—Procarbazine—brain cancer	0.000559	0.00117	CcSEcCtD
Methylphenidate—Dermatitis—Procarbazine—brain cancer	0.000559	0.00117	CcSEcCtD
Methylphenidate—Anxiety—Temozolomide—brain cancer	0.000557	0.00117	CcSEcCtD
Methylphenidate—Headache—Procarbazine—brain cancer	0.000556	0.00116	CcSEcCtD
Methylphenidate—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—brain cancer	0.000555	0.00116	CcSEcCtD
Methylphenidate—Oedema—Carmustine—brain cancer	0.000555	0.00116	CcSEcCtD
Methylphenidate—Discomfort—Temozolomide—brain cancer	0.000553	0.00116	CcSEcCtD
Methylphenidate—Infection—Carmustine—brain cancer	0.000551	0.00115	CcSEcCtD
Methylphenidate—Angiopathy—Etoposide—brain cancer	0.000548	0.00115	CcSEcCtD
Methylphenidate—Dry mouth—Temozolomide—brain cancer	0.000547	0.00114	CcSEcCtD
Methylphenidate—Immune system disorder—Etoposide—brain cancer	0.000545	0.00114	CcSEcCtD
Methylphenidate—Mediastinal disorder—Etoposide—brain cancer	0.000544	0.00114	CcSEcCtD
Methylphenidate—Thrombocytopenia—Carmustine—brain cancer	0.000543	0.00114	CcSEcCtD
Methylphenidate—Body temperature increased—Hydroxyurea—brain cancer	0.000543	0.00113	CcSEcCtD
Methylphenidate—Chills—Etoposide—brain cancer	0.000542	0.00113	CcSEcCtD
Methylphenidate—Tachycardia—Carmustine—brain cancer	0.000542	0.00113	CcSEcCtD
Methylphenidate—Confusional state—Temozolomide—brain cancer	0.000541	0.00113	CcSEcCtD
Methylphenidate—Anaphylactic shock—Temozolomide—brain cancer	0.000536	0.00112	CcSEcCtD
Methylphenidate—Oedema—Temozolomide—brain cancer	0.000536	0.00112	CcSEcCtD
Methylphenidate—Alopecia—Etoposide—brain cancer	0.000534	0.00112	CcSEcCtD
Methylphenidate—Infection—Temozolomide—brain cancer	0.000533	0.00111	CcSEcCtD
Methylphenidate—Anorexia—Carmustine—brain cancer	0.000529	0.00111	CcSEcCtD
Methylphenidate—Nausea—Procarbazine—brain cancer	0.000527	0.0011	CcSEcCtD
Methylphenidate—Nervous system disorder—Temozolomide—brain cancer	0.000526	0.0011	CcSEcCtD
Methylphenidate—Thrombocytopenia—Temozolomide—brain cancer	0.000525	0.0011	CcSEcCtD
Methylphenidate—Skin disorder—Temozolomide—brain cancer	0.000521	0.00109	CcSEcCtD
Methylphenidate—Hyperhidrosis—Temozolomide—brain cancer	0.000518	0.00108	CcSEcCtD
Methylphenidate—Anorexia—Temozolomide—brain cancer	0.000511	0.00107	CcSEcCtD
Methylphenidate—Back pain—Etoposide—brain cancer	0.000509	0.00106	CcSEcCtD
Methylphenidate—Hypersensitivity—Hydroxyurea—brain cancer	0.000506	0.00106	CcSEcCtD
Methylphenidate—Musculoskeletal discomfort—Carmustine—brain cancer	0.000505	0.00106	CcSEcCtD
Methylphenidate—Muscle spasms—Etoposide—brain cancer	0.000505	0.00106	CcSEcCtD
Methylphenidate—Insomnia—Carmustine—brain cancer	0.000502	0.00105	CcSEcCtD
Methylphenidate—Paraesthesia—Carmustine—brain cancer	0.000498	0.00104	CcSEcCtD
Methylphenidate—Dyspnoea—Carmustine—brain cancer	0.000495	0.00103	CcSEcCtD
Methylphenidate—Somnolence—Carmustine—brain cancer	0.000493	0.00103	CcSEcCtD
Methylphenidate—Asthenia—Hydroxyurea—brain cancer	0.000492	0.00103	CcSEcCtD
Methylphenidate—Musculoskeletal discomfort—Temozolomide—brain cancer	0.000488	0.00102	CcSEcCtD
Methylphenidate—Ill-defined disorder—Etoposide—brain cancer	0.000488	0.00102	CcSEcCtD
Methylphenidate—Anaemia—Etoposide—brain cancer	0.000486	0.00102	CcSEcCtD
Methylphenidate—Insomnia—Temozolomide—brain cancer	0.000485	0.00101	CcSEcCtD
Methylphenidate—Decreased appetite—Carmustine—brain cancer	0.000482	0.00101	CcSEcCtD
Methylphenidate—Paraesthesia—Temozolomide—brain cancer	0.000481	0.00101	CcSEcCtD
Methylphenidate—Gastrointestinal disorder—Carmustine—brain cancer	0.000479	0.001	CcSEcCtD
Methylphenidate—Dyspnoea—Temozolomide—brain cancer	0.000478	0.001	CcSEcCtD
Methylphenidate—Somnolence—Temozolomide—brain cancer	0.000477	0.000997	CcSEcCtD
Methylphenidate—Constipation—Carmustine—brain cancer	0.000474	0.000992	CcSEcCtD
Methylphenidate—Pain—Carmustine—brain cancer	0.000474	0.000992	CcSEcCtD
Methylphenidate—Malaise—Etoposide—brain cancer	0.000474	0.000992	CcSEcCtD
Methylphenidate—Vertigo—Etoposide—brain cancer	0.000472	0.000988	CcSEcCtD
Methylphenidate—Dyspepsia—Temozolomide—brain cancer	0.000472	0.000987	CcSEcCtD
Methylphenidate—Leukopenia—Etoposide—brain cancer	0.000471	0.000984	CcSEcCtD
Methylphenidate—Diarrhoea—Hydroxyurea—brain cancer	0.00047	0.000982	CcSEcCtD
Methylphenidate—Decreased appetite—Temozolomide—brain cancer	0.000466	0.000975	CcSEcCtD
Methylphenidate—Gastrointestinal disorder—Temozolomide—brain cancer	0.000463	0.000968	CcSEcCtD
Methylphenidate—Fatigue—Temozolomide—brain cancer	0.000462	0.000967	CcSEcCtD
Methylphenidate—Loss of consciousness—Etoposide—brain cancer	0.000462	0.000966	CcSEcCtD
Methylphenidate—Cough—Etoposide—brain cancer	0.000459	0.000959	CcSEcCtD
Methylphenidate—Constipation—Temozolomide—brain cancer	0.000459	0.000959	CcSEcCtD
Methylphenidate—Pain—Temozolomide—brain cancer	0.000459	0.000959	CcSEcCtD
Methylphenidate—Feeling abnormal—Carmustine—brain cancer	0.000457	0.000956	CcSEcCtD
Methylphenidate—Convulsion—Etoposide—brain cancer	0.000455	0.000953	CcSEcCtD
Methylphenidate—Hypertension—Etoposide—brain cancer	0.000454	0.000949	CcSEcCtD
Methylphenidate—Dizziness—Hydroxyurea—brain cancer	0.000454	0.000949	CcSEcCtD
Methylphenidate—Gastrointestinal pain—Carmustine—brain cancer	0.000454	0.000949	CcSEcCtD
Methylphenidate—Chest pain—Etoposide—brain cancer	0.000448	0.000936	CcSEcCtD
Methylphenidate—Unspecified disorder of skin and subcutaneous tissue—Etoposide—brain cancer	0.000444	0.00093	CcSEcCtD
Methylphenidate—Discomfort—Etoposide—brain cancer	0.000442	0.000925	CcSEcCtD
Methylphenidate—Feeling abnormal—Temozolomide—brain cancer	0.000442	0.000924	CcSEcCtD
Methylphenidate—Body temperature increased—Carmustine—brain cancer	0.000439	0.000917	CcSEcCtD
Methylphenidate—Abdominal pain—Carmustine—brain cancer	0.000439	0.000917	CcSEcCtD
Methylphenidate—Gastrointestinal pain—Temozolomide—brain cancer	0.000438	0.000917	CcSEcCtD
Methylphenidate—Vomiting—Hydroxyurea—brain cancer	0.000436	0.000913	CcSEcCtD
Methylphenidate—Rash—Hydroxyurea—brain cancer	0.000433	0.000905	CcSEcCtD
Methylphenidate—Confusional state—Etoposide—brain cancer	0.000433	0.000905	CcSEcCtD
Methylphenidate—Dermatitis—Hydroxyurea—brain cancer	0.000432	0.000904	CcSEcCtD
Methylphenidate—Headache—Hydroxyurea—brain cancer	0.00043	0.000899	CcSEcCtD
Methylphenidate—Anaphylactic shock—Etoposide—brain cancer	0.000429	0.000897	CcSEcCtD
Methylphenidate—Infection—Etoposide—brain cancer	0.000426	0.000892	CcSEcCtD
Methylphenidate—Urticaria—Temozolomide—brain cancer	0.000426	0.000891	CcSEcCtD
Methylphenidate—Abdominal pain—Temozolomide—brain cancer	0.000424	0.000887	CcSEcCtD
Methylphenidate—Body temperature increased—Temozolomide—brain cancer	0.000424	0.000887	CcSEcCtD
Methylphenidate—Thrombocytopenia—Etoposide—brain cancer	0.00042	0.000879	CcSEcCtD
Methylphenidate—Tachycardia—Etoposide—brain cancer	0.000419	0.000876	CcSEcCtD
Methylphenidate—Skin disorder—Etoposide—brain cancer	0.000417	0.000872	CcSEcCtD
Methylphenidate—Hyperhidrosis—Etoposide—brain cancer	0.000415	0.000868	CcSEcCtD
Methylphenidate—Anorexia—Etoposide—brain cancer	0.000409	0.000855	CcSEcCtD
Methylphenidate—Hypersensitivity—Carmustine—brain cancer	0.000409	0.000855	CcSEcCtD
Methylphenidate—Nausea—Hydroxyurea—brain cancer	0.000408	0.000853	CcSEcCtD
Methylphenidate—Asthenia—Carmustine—brain cancer	0.000398	0.000833	CcSEcCtD
Methylphenidate—Hypersensitivity—Temozolomide—brain cancer	0.000395	0.000826	CcSEcCtD
Methylphenidate—Paraesthesia—Etoposide—brain cancer	0.000385	0.000806	CcSEcCtD
Methylphenidate—Asthenia—Temozolomide—brain cancer	0.000385	0.000805	CcSEcCtD
Methylphenidate—Dyspnoea—Etoposide—brain cancer	0.000383	0.0008	CcSEcCtD
Methylphenidate—Somnolence—Etoposide—brain cancer	0.000381	0.000798	CcSEcCtD
Methylphenidate—Diarrhoea—Carmustine—brain cancer	0.00038	0.000794	CcSEcCtD
Methylphenidate—Pruritus—Temozolomide—brain cancer	0.000379	0.000793	CcSEcCtD
Methylphenidate—Decreased appetite—Etoposide—brain cancer	0.000373	0.00078	CcSEcCtD
Methylphenidate—Gastrointestinal disorder—Etoposide—brain cancer	0.00037	0.000775	CcSEcCtD
Methylphenidate—Fatigue—Etoposide—brain cancer	0.00037	0.000774	CcSEcCtD
Methylphenidate—Dizziness—Carmustine—brain cancer	0.000367	0.000767	CcSEcCtD
Methylphenidate—Pain—Etoposide—brain cancer	0.000367	0.000767	CcSEcCtD
Methylphenidate—Constipation—Etoposide—brain cancer	0.000367	0.000767	CcSEcCtD
Methylphenidate—Diarrhoea—Temozolomide—brain cancer	0.000367	0.000767	CcSEcCtD
Methylphenidate—Dizziness—Temozolomide—brain cancer	0.000355	0.000742	CcSEcCtD
Methylphenidate—Feeling abnormal—Etoposide—brain cancer	0.000354	0.000739	CcSEcCtD
Methylphenidate—Vomiting—Carmustine—brain cancer	0.000353	0.000738	CcSEcCtD
Methylphenidate—Gastrointestinal pain—Etoposide—brain cancer	0.000351	0.000734	CcSEcCtD
Methylphenidate—Rash—Carmustine—brain cancer	0.00035	0.000732	CcSEcCtD
Methylphenidate—Dermatitis—Carmustine—brain cancer	0.00035	0.000731	CcSEcCtD
Methylphenidate—Headache—Carmustine—brain cancer	0.000348	0.000727	CcSEcCtD
Methylphenidate—Vomiting—Temozolomide—brain cancer	0.000341	0.000713	CcSEcCtD
Methylphenidate—Urticaria—Etoposide—brain cancer	0.000341	0.000713	CcSEcCtD
Methylphenidate—Abdominal pain—Etoposide—brain cancer	0.000339	0.000709	CcSEcCtD
Methylphenidate—Body temperature increased—Etoposide—brain cancer	0.000339	0.000709	CcSEcCtD
Methylphenidate—Rash—Temozolomide—brain cancer	0.000338	0.000707	CcSEcCtD
Methylphenidate—Dermatitis—Temozolomide—brain cancer	0.000338	0.000706	CcSEcCtD
Methylphenidate—Headache—Temozolomide—brain cancer	0.000336	0.000703	CcSEcCtD
Methylphenidate—Nausea—Carmustine—brain cancer	0.00033	0.000689	CcSEcCtD
Methylphenidate—Nausea—Temozolomide—brain cancer	0.000318	0.000666	CcSEcCtD
Methylphenidate—Hypersensitivity—Etoposide—brain cancer	0.000316	0.000661	CcSEcCtD
Methylphenidate—Asthenia—Etoposide—brain cancer	0.000308	0.000644	CcSEcCtD
Methylphenidate—Pruritus—Etoposide—brain cancer	0.000304	0.000635	CcSEcCtD
Methylphenidate—Diarrhoea—Etoposide—brain cancer	0.000294	0.000614	CcSEcCtD
Methylphenidate—Dizziness—Etoposide—brain cancer	0.000284	0.000593	CcSEcCtD
Methylphenidate—Vomiting—Etoposide—brain cancer	0.000273	0.000571	CcSEcCtD
Methylphenidate—Rash—Etoposide—brain cancer	0.000271	0.000566	CcSEcCtD
Methylphenidate—Dermatitis—Etoposide—brain cancer	0.00027	0.000565	CcSEcCtD
Methylphenidate—Headache—Etoposide—brain cancer	0.000269	0.000562	CcSEcCtD
Methylphenidate—Nausea—Etoposide—brain cancer	0.000255	0.000533	CcSEcCtD
